Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALIFE2 trial of low molecular weight heparin in recurrent miscarriage with inherited thrombophilia
NL-OMON27965Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of low molecular weight heparin calcium in recurrent miscarriage (RPL) and Congenital Thrombophilia, sponsored by Amsterdam University Medical Center. Primary endpoint: Live birth. Started Sep 2012; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
recurrent miscarriage (RPL)Congenital Thrombophilia
Beyond the preview
Go deeper on NL-OMON27965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27965.